Search Within

Hikmat Al-Ahmadie

  1. "General Medicine Services"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (7)
  2. Department of Pathology and Laboratory Medicine (7)
  3. General Medicine Services (7)
  4. Genitourinary Oncology Service (7)
  5. Solid Tumor Oncology Division (7)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Dean Bajorin (6)
  2. Bernard Bochner (5)
  3. Gopakumar Iyer (5)
  4. Jamie Riches (5)
  5. Ashley Regazzi (4)
  6. Guido Dalbagni (4)

More People

Years
  1. 2022 (1)
  2. 2018 (2)
  3. 2016 (2)
  4. 2011 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cold Spring Harbor Molecular Case Studies (1)
  3. European Urology (1)
  4. Journal of Pathology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Cold Spring Harbor Laboratory Press (1)
  3. Elsevier Science, Inc. (1)
  4. Wiley Blackwell (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kemel, Y.; De Jesus Escano, M.; Khurram, A.; Reisz, P.; Lenis, A. T.; Goh, A. C.; Cha, E. K.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Germline SDHA mutations in children and adults with cancer
    Journal Article

    Dubard Gault, M.; Mandelker, D.; Delair, D.; Stewart, C. R.; Kemel, Y.; Sheehan, M. R.; Siegel, B.; Kennedy, J.; Marcell, V.; Arnold, A.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)
    Meeting Abstract

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Sunitinib in urothelial cancer: Clinical, pharmacokinetic, and immunohistochemical study of predictors of response
    Journal Article

    Gallagher, D. J.; Al-Ahmadie, H.; Ostrovnaya, I.; Gerst, S. R.; Regazzi, A.; Garcia Grossman, I.; Riches, J.; Gounder, S. K.; Flaherty, A. M.; Trout, A.; more...
    European Urology (2011)

    Fulltext@MSK | Save
  • Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Journal Article

    Al-Ahmadie, H. A.; Iyer, G.; Janakiraman, M.; Lin, O.; Heguy, A.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Balar, A.; more...
    Journal of Pathology (2011)

    Fulltext@MSK | Save